TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

As of Apr 1

HealthUnited States1 sourcesNeutral

Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipeline

Proceeds will support advancement of the Company's oral small molecule GLP-1 candidate and other novel cardiometabolic programs into clinical development BOULDER, Colo., March 31, 2026 /PRNewswire/ -- Ambrosia Biosciences Inc. ("Ambrosia") today announced a $100 million oversubscribed...

CP

cision pr newswire

via Pr Newswire

March 31, 2026 | 12:00 PM UTCUpdated 2h ago

Share Read original

Read the full article at Pr Newswire →

Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipeline

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments

Be respectful and constructive.

Loading comments...

Trump Hits Out at France For Closing Airspace to US Military

These awful maladies plague red states — and Trump wants to emulate them

Related Articles

Integrity Commission probing procurement practices at UHWI

Integrity Commission probing procurement practices at UHWI

Unknown-1h ago-1 sources

Faith, courage, and purpose: Highlights fr

Faith, courage, and purpose: Highlights fr

NewVision.co.ug-12h ago-1 sources

Axiom Medical Signal Summit 2026 Showcases the Power of Early Action and Complete Case Management

Benzinga-12h ago-1 sources